Evidence map›Paper›PMID 24991150›Full record

ArticleShanghai archives of psychiatry2013

Effect of combined treatment with clozapine and metformin on fasting blood glucose, insulin level, and expression of the glucose transporter-2 (GLUT2) in Sprague-Dawley rats.

Lan Gao, Gaohua Wang, Hao Liu, Chaohui Yan

Open access · greenAbstract read
In one paragraph

Article in Shanghai archives of psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lan GaoMental Health Center, People's Hospital of Wuhan University, Wuhan, Hubei Province, China.
Gaohua WangMental Health Center, People's Hospital of Wuhan University, Wuhan, Hubei Province, China.
Hao LiuMental Health Center, People's Hospital of Wuhan University, Wuhan, Hubei Province, China.
Chaohui YanMental Health Center, People's Hospital of Wuhan University, Wuhan, Hubei Province, China.
Wuhan No.9 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntipsychotic medications can cause an increase in blood glucose and the development of type II diabetes. Metformin may ameliorate these side effects.

objectiveAssess whether or not metformin reduces the abnormalities in glucose metabolism that occur with use of the antipsychotic clozapine.

methodsEighteen adult Sprague-Dawley (SD) rats were divided into three groups that were intragastrically administered saline, clozapine (20 mg/kg), or a combination of clozapine (20 mg/kg) and metformin (78 mg/kg) for 28 days. Fasting blood glucose was assessed at baseline and every seven days thereafter. The animals were euthanized on the 28(th) day at which time aortic blood was obtained to assess blood insulin and C-peptide by radioimmunoassay, and pancreatic tissue samples were collected and used to determine the expression of the glucose transporter-2 (GLUT2) by real-time polymerase chain reaction (RT-PCR) and Western Blot.

resultsFasting blood glucose in the clozapine group was significantly higher at the 14(th), 21(st), and 28(th) day compared to baseline, but rats receiving clozapine and metformin only had significantly elevated levels on the 14(th) day of treatment. However, repeated measures ANOVA found no statistically significant differences in blood glucose levels over time between the three groups (p=0.136). Multiple comparison tests found that the mean insulin level in the clozapine+metformin group was significantly lower than the levels in the clozapine and saline groups. There were statistically significant differences in the expression of GLUT2 mRNA (clozapine+metformin group < clozapine group < saline group) and in the expression of GLUT2 protein (clozapine+metformin group, clozapine group < saline group).

conclusionThis study found a non-significant increase in fasting blood glucose in SD rats treated with clozapine that was partially counteracted by concurrent administration of metformin. Rats administered clozapine showed the expected decrease in the expression of GLUT2, but concurrent administration of metformin and clozapine for 28 days did not show the expected normalization of the expression levels of GLUT2.

Identifiers

PMID24991150
PMCPMC4054550
OpenAlexW2280632320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.